Kulmbach (www.aktiencheck.de) - Emergent BioSolutions-Aktienanalyse von "Der Aktionär":
Michael Diertl vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Emergent BioSolutions Inc.…
Einen Kurssprung von rund 20 Prozent hat Emergent BioSolutions am Donnerstag hingelegt. Der Grund dafür waren deutlich besser als erwartete…
EBS earnings call for the period ending September 30, 2024.…
GAITHERSBURG, Md., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) remains committed to supporting widespread…
Die Aktie von Emergent BioSolutions verzeichnete in den letzten Wochen einen deutlichen Kursrückgang. Trotz zwischenzeitlicher Erholungsversuche notiert der Titel aktuell…
Der US-Impfstoffhersteller Emergent BioSolutions verzeichnet eine bemerkenswerte Erholung an der Börse. Nach einem dramatischen Kurssturz im vergangenen Jahr konnte die…
GAITHERSBURG, Md., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it was awarded…
New York, New York, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Oak Hill Advisors (“OHA”) served as Administrative Agent…
Der Fentanyl-Missbrauch ist in den USA in den letzten Jahren zu einem riesigen Problem geworden. Eine Lösung dafür gibt es…
Der Fentanyl-Missbrauch ist in den USA in den letzten Jahren zu einem riesigen Problem geworden. Eine Lösung dafür gibt es…
Kulmbach (www.aktiencheck.de) - Emergent BioSolutions-Aktienanalyse von "Der Aktionär":
Michael Diertl vom Anlegermagazin "Der Aktionär" rät weiterhin zum Kauf der Aktie von…
In der dieswöchigen Ausgabe 36/24 hat DER AKTIONÄR zum Kauf der Biotech-Aktie Emergent Biosolutions geraten.…
GAITHERSBURG, Md., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has completed the…
GAITHERSBURG, Md., Aug. 19, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS) today announced it is proactively working…
Emergent BioSolutions Inc. led an advance in the stocks of companies working on vaccines and antiviral products this week as…
Concerns about the mpox outbreak are causing Emergent BioSolutions shares to jump.…
EBS earnings call for the period ending June 30, 2024.…
…
…
…
GAITHERSBURG, Md., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for…
Philadelphia, PA, July 31, 2024 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, a global specialty pharmaceutical company, announced today the…
GAITHERSBURG, Md., July 24, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced the launch of…
GAITHERSBURG, Md., June 06, 2024 (GLOBE NEWSWIRE) -- In recognition of National Naloxone Awareness Day, Emergent BioSolutions Inc.…
…
GAITHERSBURG, Md., May 10, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that its 2024 Annual…
…
EBS earnings call for the period ending March 31, 2024.…
…
…
GAITHERSBURG, Md., May 01, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for…
GAITHERSBURG, Md., May 01, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced the results of…
GAITHERSBURG, Md., April 30, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced that it has entered into…
GAITHERSBURG, Md., March 25, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced that the U.S. Food and…
The Global Recombinant Vaccine Market Size was Valued at USD 8.2 Billion in 2023 and the Worldwide Recombinant Vaccine Market…
EBS earnings call for the period ending December 31, 2023.…
…
…
GAITHERSBURG, Md., March 06, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for…
Emergent BioSolutions appoints new CEO to drive growth…
…
GAITHERSBURG, Md., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS), a global company providing solutions that…
…
…
The BARDA is exercising an option to procure additional doses of Emergent BioSolutions (EBS) recently approved anthrax vaccine. Deliveries will…
Emergent BioSolutions faces NYSE non-compliance over delayed Q3 filing…
GAITHERSBURG, Md., Nov. 24, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today confirmed that on November…
By David Bautz, PhD
NASDAQ:SNGX
READ THE FULL SNGX RESEARCH REPORT
Business Update
Filovirus Vaccine Candidates Demonstrate Two-Year Stability at Elevated Temperatures
In September 2023,…
…
…